NCT03282097Completed
Decisions About Cancer Screening in Alzheimer's Disease
Source: ClinicalTrials.gov · Last updated 11 Aug 2025
Brief summary (registry, in English)
The Decisions about Cancer screening in Alzheimer's Disease (DECAD) study tests if an evidence-based decision aid for dementia caregivers can support decision-making about mammography and improve the quality of medical decision-making about breast cancer screening. This large randomized controlled trial will recruit up to 450 dyads (900 individual participants) of older women with dementia and a family caregiver, for a goal of 426 dyad baselines (852 individual participants).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 442 (actual)
- First submitted
- 11 Sept 2017
- Start date
- 1 Dec 2017
- Primary completion date
- 6 Apr 2023
- Lead sponsor
- Indiana University
- Diseases
- Alzheimer disease
- NCT number
- NCT03282097
What you commit to
- Study type: Interventional
- Participants enrolled: 442
- From 1 Dec 2017 to the primary completion date, 6 Apr 2023
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Inclusion Criteria:
- Female and 75 years or older
- At least one mammogram in the past five years
- Primary care visit scheduled in the next 12 months
- Diagnosis of Alzheimer's disease or related dementia as determined by ICD-10 code
- Ability to provide informed consent or assent
- Ability to communicate in English
- Patient Exclusion Criteria:
- Permanent resident of a nursing facility
- Had a mammogram in the past 6 months
- Primary care visit scheduled is the first visit with the PCP
- Made a decision to stop getting mammograms
- History of Atypical Ductal Hyperplasia, lobular carcinoma in situ, ductal carcinoma in situ, or non-invasive breast cancer
- Has mild cognitive impairment, serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code
- Caregiver Inclusion Criteria:
- 18 years or older
- Primary family caregiver of the patient\*
- Must have a telephone
- Ability to provide informed consent
- Ability to communicate in English
- Caregiver Exclusion Criteria:
- Caregiver is a non-family member who is not a legal Healthcare Power of Attorney
- Less than a 7th grade education\*\*
- Made a decision that the patient will stop getting mammograms
- Has a diagnosis of AD or has a serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code
Age in the registry: 75 years to - · Sex: Female · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beth Israel Deaconess Medical Center Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Parkview Health Coordinator of this site? Confirm its status | Fort Wayne | United States | Unknown status |
| Alzheimer's Association Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
| Eskenazi Health Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
| IU Health Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.